Table 2.
Comparison of plasma lipid and lipoprotein levels in patients and controls
| Patients (n) | TG (mg/dl) | TC (mg/dl) | LDL-C (mg/dl) | HDL-C (mg/dl) |
|---|---|---|---|---|
| CAD with T2DM |
202.2 ± 87.9* |
207.6 ± 185.4 |
97.8 ± 30.8** |
44.7 ± 10.5* |
| Males (52) |
206.4 ± 85.9 |
225.8 ± 253.6 |
98.6 ± 25.9 |
43.8 ± 8.2 |
| Females (50) |
197.8 ± 90.6 |
188.6 ± 56.2 |
96.8 ± 35.3 |
45.6 ± 12.5 |
| CAD without T2DM |
151.8 ± 83.2*** |
182.8 ± 36.1 |
94.1 ± 25.9** |
49.2 ± 7.5*** |
| Males (61) |
150.3 ± 93.3 |
184.2 ± 37.7 |
97.2 ± 27.6 |
48.2 ± 8.2 |
| Females (44) |
153.9 ± 67.5 |
180.8 ± 34.1 |
89.8 ± 23.1 |
50.4 ± 6.1 |
| T2DM |
200.8 ± 99.3* |
185.9 ± 45.8 |
98.5 ± 38.4** |
45.2 ± 10.2* |
| Males (51) |
198.4 ± 110.6 |
175.9 ± 41.2**** |
90.9 ± 31.3* |
42.5 ± 9.7* |
| Females (50) |
203.2 ± 87.1 |
196.2 ± 48.3 |
106.2 ± 43.3 |
47.9 ± 10.1 |
| Controls |
161.5 ± 64.5 |
176.8 ± 25.8 |
82.8 ± 17.8 |
49.8 ± 5.8 |
| Males (47) |
161.1 ± 53.5 |
179.7 ± 27.2 |
85.3 ± 17.4 |
48.4 ± 5* |
| Females (45) | 161.8 ± 74.8 | 173.7 ± 24.2 | 80 ± 17.9 | 51.3 ± 6.1 |
*p < 0.05 compared to CAD without T2DM and controls; **p < 0.05 compared to controls; ***p < 0.05 compared to CAD with T2DM and T2DM; ****p < 0.05 compared between males and females in each group.